Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Functional Protein

Recombinant Human IL7 Protein, C-His (Active)

Catalog #:   AHC96801 Specific References (50) DATASHEET
Applications: Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Expression system: Mammalian Cells
Accession: P13232
Protein length: Asp26-His177
Overview

Catalog No.

AHC96801

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Asp26-His177

Predicted molecular weight

18.4 kDa

Nature

Recombinant

Endotoxin level

< 0.01 EU/µg as determined by LAL test.

Purity

>90% as determined by SDS-PAGE.

Accession

P13232

Applications

Bioactivity, ELISA, Immunogen, SDS-PAGE, WB

Form

Lyophilized

Storage buffer

Lyophilized from a 0.2 μm filtered solution in 20 mM PB, 150 mM NaCl, pH 7.4.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

IL-7, Interleukin-7, IL7

Data Image
References

Dose Optimization of rhIL-7-hyFc for Patients With Lymphopenia Using a Neonatal Fc Receptor-Mediated Recycling-Based and Target-Mediated Drug Disposition Pharmacokinetic Model., PMID:40396986

Interleukin-7 enhances recruitment of MDSCs by regulating MCP-1 via JAK1/STAT3 signaling pathway in non-small cell lung cancer., PMID:40374882

IL-7 in autoimmune diseases: mechanisms and therapeutic potential., PMID:40313966

IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models., PMID:40244705

Endogenous IL-7 Variation in Relation to Lymphocyte Subtypes in Septic Patients., PMID:40005375

A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19., PMID:39903535

IL-7 secreted by keratinocytes induces melanogenesis via c-kit/MAPK signaling pathway in Melan-a melanocytes., PMID:39825949

Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma., PMID:39776916

The Role of PD-1/PD-L1 and IL-7 in Lymphocyte Dynamics and Sepsis Progression: A Biomarker Study in Critically Ill Patients., PMID:39684323

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment., PMID:39593187

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer., PMID:39576210

A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma., PMID:39450160

Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy., PMID:39443955

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells., PMID:39352394

IL-4, IL-7, IL-9, NT, NRP1 May Be Useful Markers in the Diagnosis of Endometrial Cancer., PMID:39334861

Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer., PMID:39240078

Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain., PMID:39186002

An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade., PMID:39142716

APOE ε4-associated downregulation of the IL-7/IL-7R pathway in effector memory T cells: Implications for Alzheimer's disease., PMID:39129310

Concentration of IL-1β, IL-7, IL-12, IL-17, CX3CL1, ITAC and relation with the seizure severity and sudden unexpected death in epilepsy patient., PMID:39096615

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma., PMID:39093440

Interleukin-7 Risk Allele, Lymphocyte Counts, and Autoantibodies for Prediction of Risk of Immune-Related Adverse Events in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma., PMID:39079513

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors., PMID:39043602

Expression pattern of serum interleukin-7 in elderly septic patients and its prognostic value for predicting short-term mortality., PMID:38795605

IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy., PMID:38744277

High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome., PMID:38114349

PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression., PMID:38058209

Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells., PMID:38033053

The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review., PMID:37566474

IL-7 germline variant: setting the stage for immune-related adverse events., PMID:36748568

In patients with primary Sjögren's syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells., PMID:36505431

IL-7 and IL-7R in health and disease: An update through COVID times., PMID:36503870

IL-7/IL7R axis dysfunction in adults with severe community-acquired pneumonia (CAP): a cross-sectional study., PMID:35907923

The role of interleukin‑7 serum level as biological marker in breast cancer: a cross‑sectional, observational, and analytical study., PMID:35794603

Association between IL-7 and primary Sjögren's syndrome: A single-center study and a systematic scoping review., PMID:35405597

Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical features., PMID:35063672

Proteomic analysis in primary T cells reveals IL-7 alters T cell receptor thresholding via CYTIP/cytohesin/LFA-1 localisation and activation., PMID:35015072

CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases., PMID:35015026

Selective dependence on IL-7 for antigen-specific CD8 T cell responses during airway influenza infection., PMID:34997007

The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines., PMID:34956167

Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS., PMID:34739914

Interleukin-7-dependent nonclassical monocytes and CD40 expression are affected in children with type 1 diabetes., PMID:34625948

IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant., PMID:34603318

Interleukin-7 Is Associated with Clinical and Pathological Activities in Immunoglobulin A Nephropathy and Protects the Renal Proximal Tubule Epithelium from Cellular Fibrosis., PMID:34596812

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)., PMID:34452927

TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma., PMID:34445415

Identification of new IL-7Rα small-molecule agonists: a multi-computational approach., PMID:34431428

Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model., PMID:34389619

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin., PMID:34325726

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases., PMID:34276694

Datasheet
$ 460
Product specifications
50 μg 460 100 μg 690

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human IL7 Protein, C-His (Active) [AHC96801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only